CharmHealth’s Post

The first two episodes of Emerging Medtech Today, by LSI are out now! In the second episode, Henry Peck is joined by Jordi Ferrer Rendé, an economist and investment director at Ship2B Ventures, a venture capital firm that invests in impact startups and focuses on healthcare, climate-related projects, and education. As impact investors, part of the exciting challenge is reconciling financial and impact outcomes that a target portfolio company must meet to be a fit. Jordi defines the three pillars in impact investing that need to be met when looking at potential deals: 1. Intentionality (what clinical need are we solving) 2. Additionality (how are we solving this clinical need?) 3. Measurement (results of impact investment — financial and social) The full episode is available now! Follow wherever you get your podcasts.

“Biotech is the most important innovation that is going to impact every single one of us.” Stephanie A. Sirota’s passion for the biotech industry is obvious from the moment you get her talking about it – even two and a half years into a bear market. In Part 2 of The Biotech Startups Podcast conversation with RTW Investments, LP’s Chief Business Officer, Steph and Jon Chee of Excedr discuss: – The challenges of investing in biotech during a bear market, and having confidence in the fundamentals of your investments – Finding your path, lessons from the dot-com bubble as a junior investment banker, and “living to fight another day” – The critical importance of recognizing market cycles, avoiding complacency and being prepared for unexpected challenges, no matter what business you’re in Steph and Jon also discuss the evolution of biotech and the investment landscape over the last decade, and where they see it going from here. It’s another must-listen episode, so head over to Apple Podcasts or Spotify for this episode and more stories only a biotech exec can tell! #biotechnology #lifesciences #podcast

Venture Capital leaders are embracing the new wave of biotech founders. Ben Hemani of Bison Ventures joined us on the podcast last week to discuss the intersection of deep tech, biotechnology, and climate sustainability. Key insights: 1️⃣ Evaluating founders and teams in early-stage ventures is an art and a science. 2️⃣ How Ben and his team are navigating the current funding climate. 3️⃣ The powerful potential of cross-disciplinary approaches in tech and biotech. (Plus, why Ben and I both love a good platform company) This episode is packed with actionable advice for entrepreneurs and investors alike. I hope you enjoy our conversation as much as I did! There's a link to the podcast episode in the comments below ⤵️ #VentureCapital #Podcast #TechInnovation #Biotechnology #StartupFunding

Venture Capital leaders are embracing the new wave of biotech founders. Ben Hemani of Bison Ventures joined us on the podcast last week to discuss the intersection of deep tech, biotechnology, and climate sustainability. Key insights: 1️⃣ Evaluating founders and teams in early-stage ventures is an art and a science. 2️⃣ How Ben and his team are navigating the current funding climate. 3️⃣ The powerful potential of cross-disciplinary approaches in tech and biotech. (Plus, why Ben and I both love a good platform company) This episode is packed with actionable advice for entrepreneurs and investors alike. I hope you enjoy our conversation as much as I did! There's a link to the podcast episode in the comments below ⤵️ #VentureCapital #Podcast #TechInnovation #Biotechnology #StartupFunding

Venture Capital leaders are embracing the new wave of biotech founders. Ben Hemani of Bison Ventures joined us on the podcast last week to discuss the intersection of deep tech, biotechnology, and climate sustainability. Key insights: 1️⃣ Evaluating founders and teams in early-stage ventures is an art and a science. 2️⃣ How Ben and his team are navigating the current funding climate. 3️⃣ The powerful potential of cross-disciplinary approaches in tech and biotech. (Plus, why Ben and I both love a good platform company) This episode is packed with actionable advice for entrepreneurs and investors alike. I hope you enjoy our conversation as much as I did! There's a link to the podcast episode in the comments below ⤵️ #VentureCapital #Podcast #TechInnovation #Biotechnology #StartupFunding

#ICYMI Recently Michael LaRhette talked with Building Biotechs: A Podcast by Recruitomics Consulting about the importance of a supportive culture within the biotech community. Thanks for repping LabCentral! 🍊 Give it a listen on Apple Podcasts, Spotify or bCast! 🎧 #WhereBiotechBegins #Podcast #BiotechBoston #LabSpaceForRent #WeAreBioDiversity #PuttingLifeInLifeSciences

Ever wondered how life science ventures get the funding they need to revolutionize the world? Tomorrow on The Angel Next Door Podcast, Marcia Dawood chats with Yaniv Sneor, co-founder of Mid Atlantic Bio Angels. Tune in for a deep dive into the challenges and strategies of investing in life science, plus some inspiring success stories. Touching on a topic that hasn’t been discussed on The Angel Next Door in a while, this episode will be a must-listen for investors and entrepreneurs alike! #AngelNextDoorPodcast #LifeScienceInvesting #StartupSuccess #Innovation #BioTech

Being an entrepreneur can be hard work… Actually no, scratch that It IS hard work 💪 If you’re in the biotech industry with bold hopes of changing the world and saving the human race, then the pressure can feel incredibly real and difficult So what are you going to do about it? 🤔 In this episode of Building Biotechs: A Podcast by Recruitomics Consulting, we’re joined by Michael LaRhette, Chief Business Officer at LabCentral! We chat about juggling responsibilities in biotech; how biotechs are saving the human race; the most important components of an entrepreneurial ecosystem; and some of the biggest obstacles when working with partners. 🎧 Click the link in the comments to listen to the full episode (and remember to subscribe!) 👇 #biotech #biotechrecruitment #buildingbiotechs

This week on the Podcast: Michael LaRhette, CBO at LabCentral In this episode, Mike talks about what makes a great entrepreneurial ecosystem like LabCentral. A thriving biotech requires a tremendous amount of support, energy, resources, and passion. Although founders often bring energy and passion, ecosystems like LabCentral can provide additional support and resources. Plus, the parties and events organized by LabCentral help the founders recharge their energy and build a stronger community. We believe that community is the foundation of great ideas, and we absolutely love the LabCentral community. Check out the links in the comments for the episode and join us in this fun conversation with a fantastic biotech builder. Building Biotechs: A Podcast by Recruitomics Consulting #buildingbiotechs #LabCentral #biotechnology #biotechstartup

🐘🐆 At this year's Startup Safari, there was a huge interest in the unusual live OXO CoffeeBreak podcast recording, with Safari participants barely fitting into the studio set up in Create.26. 💬 In the second conversation, Péter Oszkó’s guest was Laszlo Hradszki, CEO of Hiventures, and in this episode we will talk about the investment industry, including the public sector. Listen to the conversation to get up to date with the latest developments in the Hungarian industry! 💡 Link to this episode in the comment section 🔗